| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
84,571,000 |
| Market
Cap: |
160.68(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.7304 - $3.24 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Esperion Therapeutics is a pharmaceutical company focused on developing and commercializing oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol (LDL-C). Co.'s first two products were approved by the U.S. Food and Drug Administration, European Medicines Agency, and Swiss Agency for Therapeutic Products. Bempedoic acid and the bempedoic acid / ezetimibe combination tablets are oral, once-daily, non-statin, LDL-C lowering medicines for patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
59,611 |
74,217 |
| Total Buy Value |
$0 |
$0 |
$86,148 |
$171,738 |
| Total People Bought |
0 |
0 |
3 |
4 |
| Total Buy Transactions |
0 |
0 |
4 |
7 |
| Total Shares Sold |
0 |
0 |
1,913 |
51,775 |
| Total Sell Value |
$0 |
$0 |
$2,686 |
$239,770 |
| Total People Sold |
0 |
0 |
1 |
4 |
| Total Sell Transactions |
0 |
0 |
5 |
26 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Foody Joanne M. |
Chief Medical Officer |
• – – |
2023-03-17 |
4 |
S |
$1.78 |
$6,785 |
D/D |
(3,808) |
128,002 |
|
10% |
|
| Koenig Sheldon L. |
President and CEO |
• • – |
2023-03-17 |
4 |
S |
$1.78 |
$12,479 |
D/D |
(6,999) |
292,816 |
|
10% |
|
| Warren Eric |
Chief Commercial Officer |
• – – |
2023-03-17 |
4 |
S |
$1.78 |
$937 |
D/D |
(526) |
70,346 |
|
10% |
|
| Koenig Sheldon L. |
President and CEO |
• • – |
2023-03-07 |
4 |
S |
$5.06 |
$27,510 |
D/D |
(5,441) |
194,815 |
|
70% |
|
| Warren Eric |
Chief Commercial Officer |
• – – |
2023-03-07 |
4 |
S |
$5.06 |
$25,730 |
D/D |
(5,090) |
48,572 |
|
70% |
|
| Foody Joanne M. |
Chief Medical Officer |
• – – |
2023-03-07 |
4 |
S |
$5.07 |
$19,672 |
D/D |
(3,884) |
103,060 |
|
70% |
|
| Looker Benjamin |
General Counsel |
• – – |
2023-01-18 |
4 |
S |
$7.00 |
$44,404 |
D/D |
(6,347) |
64,453 |
|
79% |
|
| Foody Joanne M. |
Chief Medical Officer |
• – – |
2023-01-18 |
4 |
S |
$6.99 |
$8,319 |
D/D |
(1,191) |
106,944 |
|
79% |
|
| Halladay Benjamin |
Chief Financial Officer |
• – – |
2022-12-09 |
4 |
A |
$0.00 |
$0 |
D/D |
44,000 |
63,771 |
|
- |
|
| Halladay Benjamin |
Chief Financial OfficerOfficer |
• – – |
2022-11-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
19,771 |
|
-77% |
|
| Foody Joanne M. |
Chief Medical Officer |
• – – |
2022-10-18 |
4 |
S |
$7.69 |
$7,242 |
D/D |
(942) |
108,135 |
|
20% |
|
| Warren Eric |
Chief Commercial Officer |
• – – |
2022-10-18 |
4 |
S |
$7.69 |
$823 |
D/D |
(107) |
53,662 |
|
20% |
|
| Koenig Sheldon L. |
President and CEO |
• • – |
2022-09-19 |
4 |
S |
$6.94 |
$23,548 |
D/D |
(3,394) |
198,257 |
|
15% |
|
| Warren Eric |
Chief Commercial Officer |
• – – |
2022-09-19 |
4 |
S |
$6.92 |
$1,765 |
D/D |
(255) |
53,769 |
|
15% |
|
| Warren Eric |
Chief Commercial Officer |
• – – |
2022-08-31 |
4 |
B |
$7.46 |
$7,460 |
D/D |
1,000 |
54,024 |
2.74 |
-6% |
|
| Warren Eric |
Chief Commercial Officer |
• – – |
2022-08-17 |
4 |
S |
$6.82 |
$1,356 |
D/D |
(199) |
53,024 |
|
18% |
|
| Koenig Sheldon L. |
President and CEO |
• • – |
2022-08-05 |
4 |
B |
$5.80 |
$49,950 |
D/D |
8,606 |
198,771 |
2.81 |
1% |
|
| Foody Joanne M. |
Chief Medical Officer |
• – – |
2022-07-19 |
4 |
S |
$6.55 |
$25,552 |
D/D |
(3,901) |
109,077 |
|
0% |
|
| Warren Eric |
Chief Commercial Officer |
• – – |
2022-07-19 |
4 |
S |
$6.58 |
$2,837 |
D/D |
(431) |
53,223 |
|
0% |
|
| Warren Eric |
Chief Commercial Officer |
• – – |
2022-06-17 |
4 |
S |
$4.90 |
$1,254 |
D/D |
(256) |
53,654 |
|
-41% |
|
| Koenig Sheldon L. |
President and CEO |
• • – |
2022-06-17 |
4 |
S |
$4.99 |
$22,719 |
D/D |
(4,552) |
190,165 |
|
-41% |
|
| Carroll J Martin |
Director |
– • – |
2022-06-02 |
4 |
B |
$5.64 |
$28,180 |
D/D |
5,000 |
5,000 |
2.39 |
41% |
|
| Warren Eric |
Chief Commercial Officer |
• – – |
2022-05-17 |
4 |
S |
$5.98 |
$1,172 |
D/D |
(196) |
53,910 |
|
-8% |
|
| Koenig Sheldon L. |
President and CEO |
• • – |
2022-03-17 |
4 |
S |
$4.58 |
$2,615 |
D/D |
(571) |
194,717 |
|
-20% |
|
| Bartram Richard |
Chief Financial Officer |
• – – |
2022-03-14 |
4 |
A |
$0.00 |
$0 |
D/D |
37,000 |
82,751 |
|
- |
|
250 Records found
|
|
Page 2 of 10 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.09 (4.52%) 
